Treatment of paediatric cerebral palsy with Dysport®

Hospital Medicine

Volumn 61, Issue 10, 2000, Pages 718-721

  Ubhi, Tim ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN A; HEMAGGLUTININ;

ADOLESCENT; CEREBRAL PALSY; CHILD; DRUG COMBINATION; HUMAN; INFANT; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REVIEW; SPASTICITY;

ADOLESCENT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; HEMAGGLUTININS; HUMANS; INFANT; MUSCLE SPASTICITY;

EID: 0034293484     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2000.61.10.1443     Document Type: Article

References (14)

1. Bakheit MO (1999) Dysport (botulinum toxin type A) in the management of pédiatrie spasticity associated with cerebral palsy: results of a retrospective, multicentre study. Basic and Therapeutic Aspects Toxins. International Conference. Orlando. November 16-18: 75-6
2. Bax M (1964) Terminology and classification of Cf. Dev Med Child Neural 6: 295-7
3. Blair E. Stanley FJ (1982) An epidemiological study of cerebral palsy in Western Australia. 1956-1975. III postnatal aetiology. Der Med Child Neurol 27:615
4. Corry IS, Cosgrove AP, Duffy DM, McNeill S. Taylor TC, Graham HK (1998) Botulinum Toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 18(3): 304-11
5. Cosgrove AP. Graham HK (1995) Cerebral palsy. In: Moore AP, ed. Handbook of BoniUnum Toxin Treatment. Blackwell Science. Oxford: 222-47
6. De Paiva A, Meunier FA, Molgo J, Aoki R. Molly J (1999) Functional repair of motor end plates after botulinum toxin Type A poisoning -biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Nat Acad Sci USA 96: 3200-5
7. Eames NWA Baker R, Hill N, Graham K. Taylor T. Cosgrove A (1999) The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol 41: 226-32
8. Glanzman RL, Gelb D.I, Drury I, Bromberg MB, Truong DD (1990) Brachial plexopathy after botulinum toxin injections. Neurology 40: 1143
9. Heinen F. Wissel J, Philipsen A et al (1997) Interventional neuropediatrics: Treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A. Neuropediatrics 28:307-13
10. Ranson SW, Dixon HH ( 1928) The elasticity and ductility of muscle in the myostatic contracture caused by tetanus toxin. Am J Physiol 86: 312-19
11. Sampaio C, Castro-Caldas A, Sales-Luis MI, Alves M. Pinto L. Apolinario P (1993) Brachial plexopathy after botulinum toxin administration for cervical dystonia. J Neurol Neumsurg Psvchiatiy 56: 220-1
12. Sheean GL. Murray NMF, Marsden CD (1995) Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp. Lancet 346: 154-6
13. Tabary JC, Tabarcy C, Tardieu C, Tardieu G. Goldspink G (1972) Physiological and structural changes in the cat's soleus muscle due to immobilization at different lengths by plaster casts. J Phvsiol (Land) 224: 231 -44
14. Ubhi T, Bhakta B, Ives'HL, Allgar V, Roussounis SH (2000) Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dix Childhood (in press)